-
1
The treatment of autoimmune hemolytic anemia with complement inhibitor iptacopan: a case report
Published 2025-03-01Subjects: Get full text
Article -
2
-
3
-
4
Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERS
Published 2025-08-01Subjects: “…complement inhibitor…”
Get full text
Article -
5
Consensus on Complement Inhibitor Therapy and Management of Paroxysmal Nocturnal Hemoglobinuria
Published 2025-01-01Subjects: Get full text
Article -
6
A 2-decade survival from a double hemolytic disease: A case of paroxysmal nocturnal hemoglobinuria with hemoglobinopathy
Published 2024-12-01Subjects: “…complement inhibitors…”
Get full text
Article -
7
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
Published 2025-06-01Subjects: Get full text
Article -
8
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients
Published 2025-06-01Subjects: Get full text
Article -
9
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
Published 2025-04-01Subjects: Get full text
Article -
10
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
Published 2024-12-01Subjects: Get full text
Article -
11
Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled...
Published 2024-11-01Subjects: “…complement inhibitors…”
Get full text
Article